Algiecel, a Copenhagen-based microalgae company, has appointed two senior female leaders to its management team as it prepares to accelerate commercial production of its marine bioactives platform. The company named Mette Ingeman Pedersen as Chief Financial Officer and Tove Feld as Chair of the Board, signaling a strategic focus on strengthening governance and operational infrastructure during a critical growth phase.
The appointments coincide with the company securing €8 million (DKK 60 million, $8.7 million) in funding to support its expansion plans. The capital will be directed toward scaling commercial production capabilities and building the financial, operational and governance infrastructure needed to support the firm’s ambitions in the nutrition, pet food and personal care sectors.
Leadership Strengthens Female Representation
The two appointments underscore Algiecel’s commitment to gender diversity in senior management. Pedersen, the newly appointed CFO, brings extensive financial expertise to guide the company through its next phase of growth. In a statement, she emphasized the importance of rigorous financial management during periods of commercial expansion: “Algiecel is entering a decisive stage, where strong financial discipline must support ambitious commercial execution.”
Feld’s appointment as Board Chair provides additional governance oversight at a time when the company is transitioning from early-stage development toward mainstream commercial operations. Together, the appointments strengthen the leadership team as Algiecel navigates the complexities of scaling production while maintaining quality and sustainability standards.
Scaling Sustainable Ingredients
Founded in 2021, Algiecel has developed a microalgae-based platform designed to produce bioactive ingredients derived from marine sources. The company targets multiple markets, including nutritional supplements, animal nutrition for pet food applications, and the personal care and cosmetics sectors—all areas experiencing growing demand for sustainable, naturally derived alternatives to synthetic ingredients.
The microalgae sector has attracted increasing attention from investors and corporations seeking sustainable solutions to replace conventional ingredient sourcing. Companies operating in this space position their products as environmentally friendly options that require fewer resources than traditional agricultural production methods while offering specific bioactive benefits.
Danish Startup Ecosystem Context
The appointment and funding round reflect the broader maturation of Denmark’s startup ecosystem, particularly in the biotech and sustainable ingredients space. Copenhagen has developed a notable cluster of companies focused on sustainable food production and biotechnology, supported by strong academic institutions and investor networks. The presence of experienced executives like Pedersen and Feld willing to take on roles at growth-stage companies suggests increasing confidence in the commercial viability of European biotech ventures.
As European regulators continue to support sustainability initiatives and consumers demonstrate growing interest in natural ingredients, companies like Algiecel are well-positioned to capture market opportunities across multiple industries simultaneously.